Sign In

Login

Password

Forgot Password ? Sign Up

بيكالوتاميد (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "بيكالوتاميد" in Arabic language version.

refsWebsite
Global rank Arabic rank
12web.archive.org
1st place
1st place
9doi.org
2nd place
5th place
9books.google.com
3rd place
8th place
9nih.gov
4th place
6th place
1wikidata.org
43rd place
2nd place
1drugs.com
399th place
241st place
1archive.org
6th place
3rd place
1fda.gov
447th place
393rd place
1antialabs.com
low place
low place

antialabs.com

archive.org

books.google.com

doi.org

  • Cockshott ID (2004). "Bicalutamide: clinical pharmacokinetics and metabolism". Clinical Pharmacokinetics. ج. 43 ع. 13: 855–878. DOI:10.2165/00003088-200443130-00003. PMID:15509184. These data indicate that direct glucuronidation is the main metabolic pathway for the rapidly cleared (S)-bicalutamide, whereas hydroxylation followed by glucuronidation is a major metabolic pathway for the slowly cleared (R)-bicalutamide.
  • Gooren، LJ (31 مارس 2011). "Clinical practice. Care of transsexual persons". The New England Journal of Medicine. ج. 364 ع. 13: 1251–7. DOI:10.1056/nejmcp1008161. PMID:21449788.
  • Yuan J، Desouza R، Westney OL، Wang R (2008). "Insights of priapism mechanism and rationale treatment for recurrent priapism". Asian Journal of Andrology. ج. 10 ع. 1: 88–101. DOI:10.1111/j.1745-7262.2008.00314.x. PMID:18087648.
  • Elliott S، Latini DM، Walker LM، Wassersug R، Robinson JW (2010). "Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life". The Journal of Sexual Medicine. ج. 7 ع. 9: 2996–3010. DOI:10.1111/j.1743-6109.2010.01902.x. PMID:20626600.
  • Wellington K، Keam SJ (2006). "Bicalutamide 150mg: a review of its use in the treatment of locally advanced prostate cancer" (PDF). Drugs. ج. 66 ع. 6: 837–50. DOI:10.2165/00003495-200666060-00007. PMID:16706554. مؤرشف من الأصل (PDF) في 28 August 2016. اطلع عليه بتاريخ أغسطس 2020. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ الوصول= (مساعدة)
  • Lee K، Oda Y، Sakaguchi M، Yamamoto A، Nishigori C (مايو 2016). "Drug-induced photosensitivity to bicalutamide – case report and review of the literature". Photodermatology, Photoimmunology & Photomedicine. ج. 32 ع. 3: 161–4. DOI:10.1111/phpp.12230. PMID:26663090.
  • Lee K، وآخرون (2016). "Drug-induced photosensitivity to bicalutamide – case report and review of the literature". Reactions Weekly. ج. 1612 ع. 1: 37–37. DOI:10.1007/s40278-016-19790-1.
  • Singh SM، Gauthier S، Labrie F (فبراير 2000). "Androgen receptor antagonists (antiandrogens): structure-activity relationships". Current Medicinal Chemistry. ج. 7 ع. 2: 211–47. DOI:10.2174/0929867003375371. PMID:10637363.
  • Wirth MP، Hakenberg OW، Froehner M (فبراير 2007). "Antiandrogens in the treatment of prostate cancer". European Urology. ج. 51 ع. 2: 306–13, discussion 314. DOI:10.1016/j.eururo.2006.08.043. PMID:17007995.

drugs.com

  • "Bicalutamide". The American Society of Health-System Pharmacists. مؤرشف من الأصل في 29 ديسمبر 2016. اطلع عليه بتاريخ 8 ديسمبر 2016.

fda.gov

accessdata.fda.gov

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Cockshott ID (2004). "Bicalutamide: clinical pharmacokinetics and metabolism". Clinical Pharmacokinetics. ج. 43 ع. 13: 855–878. DOI:10.2165/00003088-200443130-00003. PMID:15509184. These data indicate that direct glucuronidation is the main metabolic pathway for the rapidly cleared (S)-bicalutamide, whereas hydroxylation followed by glucuronidation is a major metabolic pathway for the slowly cleared (R)-bicalutamide.
  • Gooren، LJ (31 مارس 2011). "Clinical practice. Care of transsexual persons". The New England Journal of Medicine. ج. 364 ع. 13: 1251–7. DOI:10.1056/nejmcp1008161. PMID:21449788.
  • Yuan J، Desouza R، Westney OL، Wang R (2008). "Insights of priapism mechanism and rationale treatment for recurrent priapism". Asian Journal of Andrology. ج. 10 ع. 1: 88–101. DOI:10.1111/j.1745-7262.2008.00314.x. PMID:18087648.
  • Elliott S، Latini DM، Walker LM، Wassersug R، Robinson JW (2010). "Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life". The Journal of Sexual Medicine. ج. 7 ع. 9: 2996–3010. DOI:10.1111/j.1743-6109.2010.01902.x. PMID:20626600.
  • Wellington K، Keam SJ (2006). "Bicalutamide 150mg: a review of its use in the treatment of locally advanced prostate cancer" (PDF). Drugs. ج. 66 ع. 6: 837–50. DOI:10.2165/00003495-200666060-00007. PMID:16706554. مؤرشف من الأصل (PDF) في 28 August 2016. اطلع عليه بتاريخ أغسطس 2020. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ الوصول= (مساعدة)
  • Lee K، Oda Y، Sakaguchi M، Yamamoto A، Nishigori C (مايو 2016). "Drug-induced photosensitivity to bicalutamide – case report and review of the literature". Photodermatology, Photoimmunology & Photomedicine. ج. 32 ع. 3: 161–4. DOI:10.1111/phpp.12230. PMID:26663090.
  • Singh SM، Gauthier S، Labrie F (فبراير 2000). "Androgen receptor antagonists (antiandrogens): structure-activity relationships". Current Medicinal Chemistry. ج. 7 ع. 2: 211–47. DOI:10.2174/0929867003375371. PMID:10637363.
  • Wirth MP، Hakenberg OW، Froehner M (فبراير 2007). "Antiandrogens in the treatment of prostate cancer". European Urology. ج. 51 ع. 2: 306–13, discussion 314. DOI:10.1016/j.eururo.2006.08.043. PMID:17007995.

pubchem.ncbi.nlm.nih.gov

web.archive.org

wikidata.org